Screening for sickle cell and thalassaemia in primary care: A cost-effectiveness study

British Journal of General Practice

Volumn 61, Issue 591, 2011, Pages

  Bryan, Stirling ^a,b   Dormandy, Elizabeth ^c   Roberts, Tracy ^a   Ades, Anthony ^d   Barton, Pelham ^a   Juarez Garcia, Ariadna ^a   Andronis, Lazaros ^a   Karnon, Jonathan ^e   Marteau, Theresa M ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Antenatal diagnosis; Cost effectiveness; Hemoglobin S disease; Primary care; Thalassemia

Indexed keywords

ARTICLE; CONSULTATION; COST EFFECTIVENESS ANALYSIS; ETHNIC GROUP; FATHER; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HETEROZYGOTE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIDWIFE; MODEL; MOTHER; NATIONAL HEALTH SERVICE; PATIENT COUNSELING; PREGNANCY; PREGNANCY TERMINATION; PRENATAL SCREENING; PRIMARY MEDICAL CARE; SCREENING TEST; SICKLE CELL ANEMIA; THALASSEMIA;

ABORTION, INDUCED; ANEMIA, SICKLE CELL; CLUSTER ANALYSIS; COST-BENEFIT ANALYSIS; COUNSELING; FEMALE; HUMANS; LONDON; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL DIAGNOSIS; PRIMARY HEALTH CARE; THALASSEMIA;

EID: 83455244721     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X601325     Document Type: Article

References (18)

1. Dormandy E, Gulliford MC, Reid EP, et al. Delay between pregnancy confirmation and sickle cell thalassaemia screening: a population-based cohort study. Br J Gen Pract 2008; 58(548): 154-159. (Pubitemid 351377062)
2. Dormandy E, Bryan S, Gulliford M, et al. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technol Assess 2010; 14(20): 1-160.
3. Dormandy E, Gulliford M, Bryan S, et al. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ 2010; 341: c5132.
4. Zeuner D, Ades AE, Karnon J, et al. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess 1999; 3(11): i-v, 1-186.
5. Department of Health. NHS reference costs 2005-2006. London: Department of Health, 2006. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPo licyAndGuidance/DH-062884 (accessed 13 Apr 2011).
6. Curtis L, Netten A. Unit costs of health and social care 2006. Canterbury: Personal Social Services Research Unit, University of Kent, 2006.
7. Curtis L. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent, 2010.
8. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000; 10: 325-337.
9. Doubilet P, Begg CB, Weinstein MC, et al. Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 1985; 5(2): 157-177. (Pubitemid 16130640)
10. Office for National Statistics. Census 2001. London: ONS, 2003.
11. Bellis MA, Hughes K, Hughes S, Ashton JR. Measuring paternal discrepancy and its public health consequences. J Epidemiol Community Health 2005; 59(9): 749-754. (Pubitemid 41176190)
12. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002; 360(9344): 1489-1497. (Pubitemid 35356329)
13. Roberts TE, Robinson S, Barton PM, et al. The cost-effectiveness of home based population screening for Chlamydia trachomatis in the UK: economic evaluation of the Chlamydia Screening Studies (ClaSS) Project. BMJ 2007; 335(7614): 291-294. (Pubitemid 47280805)
14. Bricker L, Garcia J, Henderson J, et al. Ultrasound and screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women's views. Health Technol Assess 2000; 4(16): i-vi, 1-193.
15. Karnon J, Goyder E, Tappenden P, et al. A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess 2007; 11(52): iii-iv, ix-xi, 1-145.
16. Cronin EK, Normand C, Henthorn JS, et al. Organisation and cost-effectiveness of antenatal haemoglobinopathy screening and follow up in a community-based programme. Br J Obstet Gynaecol 2000; 107(4): 486-491. (Pubitemid 30160538)
17. Phelan L. An analysis of the relative costs and potential benefits of different policies for antenatal screening for B thalassaemia trait and variant haemoglobins. J Clin Pathol 1999; 52(9): 697-700. (Pubitemid 29456910)
18. Gallivan S, Jit M, Utley M, Lilford RJ. A stochastic model to evaluate options for antenatal genetic screening. CORU Working Paper - CORU Research Report 672. London: University College, 2003.